The Role of Targeted Focal Therapy in the Management of Low-Risk Prostate Cancer: Update on Current Challenges
Prostate cancer is one of the most prevalent cancers among men in the United States, second only to nonmelanomatous skin cancer. Since prostate-specific antigen (PSA) testing came into widespread use in the late 1980s, there has been a sharp increase in annual prostate cancer incidence. Cancer-speci...
Saved in:
Main Authors: | Daniel W. Smith, Diliana Stoimenova, Khadijah Eid, Al Barqawi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Prostate Cancer |
Online Access: | http://dx.doi.org/10.1155/2012/587139 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy
by: Al B. Barqawi, et al.
Published: (2012-01-01) -
Focal Treatment of Prostate Cancer with Vascular-Targeted Photodynamic Therapy
by: Scott E. Eggener, et al.
Published: (2008-01-01) -
Focal Therapy for Prostate Cancer: Recent Advances and Insights
by: Francesco Lasorsa, et al.
Published: (2024-12-01) -
Focal Cryoablation of Prostate: A Review
by: Duke K. Bahn, et al.
Published: (2008-01-01) -
Feasibility and safety of targeted focal microwave ablation of the index tumor in patients with low to intermediate risk prostate cancer: Results of the FOSTINE trial.
by: Nicolas Barry Delongchamps, et al.
Published: (2021-01-01)